These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 14565803)

  • 1. Leukocytoclastic vasculitis related to rofecoxib.
    Palop-Larrea V; Melchor-Penella MA; Ortega-Monzó C; Martínez-Mir I
    Ann Pharmacother; 2003 Nov; 37(11):1731-2. PubMed ID: 14565803
    [No Abstract]   [Full Text] [Related]  

  • 2. Cutaneous vasculitis induced by cyclo-oxygenase-2 selective inhibitors.
    Drago F; Brusati C; Desirello G; Cacciapuoti M; Rebora A
    J Am Acad Dermatol; 2004 Dec; 51(6):1029-30. PubMed ID: 15583611
    [No Abstract]   [Full Text] [Related]  

  • 3. Severe cholestasis and acute renal failure related to rofecoxib.
    Linares P; Vivas S; Jorquera F; Olcoz JL; de Leon B; Oritz de Urbina J
    Am J Gastroenterol; 2004 Aug; 99(8):1622-3. PubMed ID: 15307886
    [No Abstract]   [Full Text] [Related]  

  • 4. Orlistat-induced cutaneous leukocytoclastic vasculitis.
    Gonzalez-Gay MA; Garcia-Porrua C; Lueiro M; Fernandez ML
    Arthritis Rheum; 2002 Oct; 47(5):567. PubMed ID: 12382312
    [No Abstract]   [Full Text] [Related]  

  • 5. Severe upper gastrointestinal bleeding during treatment with rofecoxib for osteoarthritis.
    Caroli A; Monica F
    Am J Gastroenterol; 2001 May; 96(5):1663-5. PubMed ID: 11374736
    [No Abstract]   [Full Text] [Related]  

  • 6. Orlistat-induced bullous leukocytoclastic vasculitis.
    Lazic T; Fonder M; Robinson-Bostom L; Wilkel CS; Della Torre L
    Cutis; 2013 Mar; 91(3):148-9. PubMed ID: 23617088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Rofecoxib-related cutaneous vasculitis].
    Defuentes G; Lecoules S; Coutant G; Algayres JP
    Presse Med; 2005 Aug; 34(14):1007-8. PubMed ID: 16225254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute pancreatitis associated with rofecoxib.
    Amaravadi RK; Jacobson BC; Solomon DH; Fischer MA
    Am J Gastroenterol; 2002 Apr; 97(4):1077-8. PubMed ID: 12003405
    [No Abstract]   [Full Text] [Related]  

  • 9. [Allergic vasculitis following ingestion of celecoxib?].
    Gscheidel D; Daspet MK; Le Coz CJ; Lipsker D
    Hautarzt; 2002 Jul; 53(7):488-91. PubMed ID: 12219273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rofecoxib and cytomegalovirus in acute flare-up of ulcerative colitis: coprecipitants or coincidence?
    Goh J; Wight D; Parkes M; Middleton SJ; Hunter JO
    Am J Gastroenterol; 2002 Apr; 97(4):1061-2. PubMed ID: 12003391
    [No Abstract]   [Full Text] [Related]  

  • 11. Cutaneous vasculitis related to celecoxib.
    Skowron F; Bérard F; Bernard N; Balme B; Perrot H
    Dermatology; 2002; 204(4):305. PubMed ID: 12077531
    [No Abstract]   [Full Text] [Related]  

  • 12. Rofecoxib-induced pseudoporphyria.
    Markus R; Reddick ME; Rubenstein MC
    J Am Acad Dermatol; 2004 Apr; 50(4):647-8. PubMed ID: 15034522
    [No Abstract]   [Full Text] [Related]  

  • 13. [Rofecoxib-induced aquagenic edema with puckering of the palms of the hands: the first case].
    Schmutz JL; Barbaud A; Trechot P
    Ann Dermatol Venereol; 2003; 130(8-9 Pt 1):813. PubMed ID: 14576620
    [No Abstract]   [Full Text] [Related]  

  • 14. Exacerbation of Crohn's colitis with severe colonic hemorrhage in a patient on rofecoxib.
    Gornet JM; Hassani Z; Modiglian R; Lémann M
    Am J Gastroenterol; 2002 Dec; 97(12):3209-10. PubMed ID: 12492220
    [No Abstract]   [Full Text] [Related]  

  • 15. Adverse oral reactions associated with the COX-2 inhibitor rofecoxib.
    Bagán JV; Thongprasom K; Scully C
    Oral Dis; 2004 Nov; 10(6):401-3. PubMed ID: 15533219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracranial hypertension induced by rofecoxib.
    Jacob S; Rajabally YA
    Headache; 2005 Jan; 45(1):75-6. PubMed ID: 15663617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lessons learned after the withdrawal of rofecoxib.
    Giaquinta D
    Manag Care Interface; 2004 Nov; 17(11):25-6, 46. PubMed ID: 15573801
    [No Abstract]   [Full Text] [Related]  

  • 18. Rofecoxib (Vioxx) withdrawal: do product monographs adequately inform physicians?
    Can Fam Physician; 2005 Feb; 51(2):212-3. PubMed ID: 15751564
    [No Abstract]   [Full Text] [Related]  

  • 19. Lessons on prescribing and drug safety from the withdrawal of rofecoxib.
    Nelson M; Cicuttini F
    Aust Fam Physician; 2004 Dec; 33(12):965-6. PubMed ID: 15630913
    [No Abstract]   [Full Text] [Related]  

  • 20. Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults.
    Solomon DH; Schneeweiss S; Glynn RJ; Kiyota Y; Levin R; Mogun H; Avorn J
    Circulation; 2004 May; 109(17):2068-73. PubMed ID: 15096449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.